Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial.
Wu SY, Jin X, Liu Y, Wang ZY, Zuo WJ, Ma D, Xiao Y, Fu T, Xiao YL, Chen L, Liu XY, Fan L, Wang ZH, Shen M, Liu R, Chai WJ, Shao ZM, Jiang YZ.
Wu SY, et al. Among authors: ma d.
Nat Med. 2025 Jun 25. doi: 10.1038/s41591-025-03776-7. Online ahead of print.
Nat Med. 2025.
PMID: 40563015